About Imgenex India
Imgenex India is a company based in Bhubaneswar (India) founded in 2004 by Sujay Singh. Imgenex India has raised $297.15 thousand across 3 funding rounds from investors including Department of Biotechnology and CliniSciences. The company has 31 employees as of April 06, 2024. Imgenex India offers products and services including Therapeutic Antibodies, Stable Cell Lines, Custom Antibody Development, Protein Production, and Drug Discovery Screening. Imgenex India operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Sino Biological, among others.
- Headquarter Bhubaneswar, India
- Employees 31 as on 06 Apr, 2024
- Founders Sujay Singh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imgenex India Private Limited
- Date of Incorporation 04 Jun, 2004
- Jurisdiction Bhubaneswar, Orissa, India
-
Annual Revenue
$487.28 K (USD)26.33as on Mar 31, 2023
-
Net Profit
-$93.16 K (USD)-845.95as on Mar 31, 2023
-
EBITDA
-$33.47 K (USD)-151.33as on Mar 31, 2023
-
Total Equity Funding
$297.15 K (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Department of Biotechnology
& 1 more
-
Employee Count
31
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imgenex India
Imgenex India offers a comprehensive portfolio of products and services, including Therapeutic Antibodies, Stable Cell Lines, Custom Antibody Development, Protein Production, and Drug Discovery Screening.
Antibodies for therapeutic and diagnostic applications.
Development of cell lines for protein production and assays.
Tailored antibody production for research needs.
Large-scale purification of proteins using various systems.
Services to identify compounds modulating biomolecular pathways.
Funding Insights of Imgenex India
Imgenex India has successfully raised a total of $297.15K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Imgenex India
Imgenex India has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Department of Biotechnology and CliniSciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked | |
|
Provides reagents and instruments for scientific research in biology fields.
|
Locked | Locked | Locked |
Investor details for Imgenex India
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Imgenex India
Investment portfolio details for Imgenex India
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imgenex India
Detailed financials for Imgenex India
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imgenex India Comparisons
Peer comparison for Imgenex India
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imgenex India
Imgenex India operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Sino Biological, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
Detailed competitors of Imgenex India
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imgenex India
Complete news archive for Imgenex India
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imgenex India
Imgenex India was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Imgenex India is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.
Sujay Singh is the current CEO of Imgenex India. They have also founded this company.
Imgenex India is a funded company, having raised a total of $297.15K across 3 funding rounds to date.
As of Apr 06, 2024, the latest employee count at Imgenex India is 31.
Annual revenue of Imgenex India is $487.28K as on Mar 31, 2023.
Imgenex India is an antibody and reagent developing company providing custom services in antibody development, recombinant protein production, and stable cell line development. It is also carrying out research projects in the areas of osteoporosis, cancer, and stem cells and inflammatory diseases either independently or in collaboration with national and international institutions. Its projects include developing a peptide-based therapy for osteoporosis in collaboration with Institute of Life Sciences (ILS), developing high expression plasmid vectors for production of biosimilar Herceptin and other recombinant proteins and bioprocess development for production of biosimilar Trastuzumab in phase II.
Imgenex India's top competitors include LabCorp, Charles River Laboratories and Cytel.
Imgenex India offers Therapeutic Antibodies, Stable Cell Lines, Custom Antibody Development, Protein Production, and Drug Discovery Screening.
Imgenex India has 2 investors. Key investors include Department of Biotechnology, and CliniSciences.
The valuation of Imgenex India is $317.62K as of Jan 2007.